KALA BIO KALA 深 沪
等待开盘 11-05 09:30:00 美东时间
0.1781
+0.005
+2.95%
华盛通- 最 高0.1852
- 今 开0.1799
- 成交量 8.21万股
- 最 低 0.1721
- 昨 收 0.173
- 总市值 344.44万
- 52周最高 95.50
- 市盈率 静 --
- 换手率 0.42%
- 52周最低 0.1146
- 委 比 55.56%
- 总股本 1933.98万
- 历史最高 66875.00
- 量 比 0.46
- 振 幅 7.57%
- 历史最低 0.1146
- 每 手 1
- 风险率 14.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多KALA BIO Stockholders Approve Key Corporate Proposals
The latest announcement is out from KALA BIO ( ($KALA) ). KALA BIO stockholders...
11-04 05:38
KALA Bio (KALA) Shares Soar 57% After Hours: Here's Why
Kala Bio Inc. (NASDAQ:KALA) shares rose 57.10% to $0.79 in after-hours trading Tuesday after the company announced it had signed a non-binding letter of intent to acquire a nationwide telehealth platform. KALA Bio is a clinical-stage biopharmaceutical company building an on-premises AI infrastructur...
09-30 13:17
KALA Bio Inks Letter Of Intent To Acquire U.S.-Based Management Services Firm For ~$15M
KALA Bio, Inc. (NASDAQ:KALA) ("KALA" or the "Company") today announced that on September 24, 2026, it signed a non-binding letter of intent ("LOI") for the proposed acquisition of 100% of a privately held, U.S.-based management services organization ("MSO") supporting a LegitScript-certified, NABP-a...
09-29 19:33
KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
KALA BIO, Inc. has appointed Yenvy Truong, founder of The LSM Group, to its advisory team to support its growth in diagnostics, genetic testing, and preventive health, enhanced by AI. Truong brings over two decades of experience in healthcare operations, including building diagnostic laboratories and advising on mergers, acquisitions, and financings totaling over $200 million. KALA aims to expand its business through existing operations, partners...
09-17 11:30
KALA BIO Updates Annual Meeting and Proposal Deadlines
KALA BIO ( ($KALA) ) has shared an update. On September 9, 2026, KALA BIO’s Boa...
09-10 06:23
KALA BIO shares are trading lower. The company announced it has entered into a letter of intent with Virotek.
KALA BIO shares are trading lower. The company announced it has entered into a letter of intent with Virotek.
09-01 22:59
Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent increase over losses of $(85.64) per share from the same period last year. The company reported $0.00 in sales this quarter. This is the same as the same period last year.
08-20 05:07
KALA BIO Announces Brief Delay in Quarterly Filing
KALA BIO ( ($KALA) ) has released a notification of late filing. KALA BIO, Inc....
08-15 00:35
Kala Bio Files Prospectus Supplement for New Securities Offering
An update from KALA BIO ( ($KALA) ) is now available. On July 22, 2026, Kala Bi...
07-23 18:35
Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same
05-16 07:12
